abstract |
The present invention relates to novel antagonists of CCR2 (CC chemokine receptor 2) and their use to provide drugs for treating symptoms and diseases, particularly pulmonary and pain diseases such as asthma and COPD. [Solution] Formula (I) [Chemical 1] (I) And their acid addition salt forms with pharmacologically acceptable acids. [Selection figure] None |